Figure 14

Comparison of anticancer activity of CMT and CMT-AgNPs against A549 cell lines (human lung cancer cells). Data was shown as the mean ± standard deviation (experiments = 3), ***p < 0.001 compared to untreated cells.

Comparison of anticancer activity of CMT and CMT-AgNPs against A549 cell lines (human lung cancer cells). Data was shown as the mean ± standard deviation (experiments = 3), ***p < 0.001 compared to untreated cells.